New Key Statistics Module, Z-Score and F-Score
NAS:FENC Key Ratios
| Market Cap $ M | 394.11 |
| Enterprise Value $ M | 357.57 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 37.89 |
| Price/Book | 9.11 |
| Price/Sales | 6.20 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 59.00 |
| EPS (TTM) $ | -0.13 |
| Beneish M-Score | -1.91 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -164.94 |
| EV-to-EBITDA | -173.23 |
| PEG | -- |
| Shares Outstanding M | 35.07 |
| Net Margin (%) | -5.41 |
| Operating Margin % | -1.90 |
| Pre-tax Margin (%) | -5.16 |
| Quick Ratio | 5.66 |
| Current Ratio | 5.85 |
| ROA % (ttm) | -5.15 |
| ROE % (ttm) | -15.45 |
| ROIC % (ttm) | -5.29 |
| Dividend Yield % | -- |
| Altman Z-Score | 4.40 |
FENC Number of Guru Trades
FENC Volume of Guru Trades
Gurus Latest Trades with NAS:FENC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:FENC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Fennec Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:FENC
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers